60 likes | 74 Views
The pegfilgrastim biosimilars market consists of the sales of pegfilgrastim biosimilars and related services by entities (organizations, sole traders and partnerships) that use them for the treatment of febrile neutropenia u2013 a life-threatening complication of cancer chemotherapy and to increase the production of infection-fighting white blood cells following transplantation. It is a recombinant human granulocyte colony stimulating factor (G-CSF) and helps to stimulate the production of infection-fighting white blood cells (neutrophils) for the treatment of cancer patients undergoing chemothera
E N D
Pegfilgrastim Biosimilars Market - Insights Overview, Top Industry Players, Size, Growth 2022-2031
Pegfilgrastim Biosimilars Market Characteristics: The global pegfilgrastim biosimilars market reached a value of nearly $902.1 million in 2020. The pegfilgrastim biosimilars market is expected to grow from $902.1 million in 2020 to $1,801.0 million in 2025 at a rate of 14.8%. The growth in the pegfilgrastim biosimilars market is mainly due to an increased prevalence of cancer and increasing adoption of the biosimilars. The pegfilgrastim biosimilars market is then expected to grow at a CAGR of 17.5% from 2025 and reach $4,037.1 million in 2030. The pegfilgrastim biosimilarsmarket’s segments- By Distribution Channel By Application Hospital Pharmacies, Retail Pharmacies, Mail-Order Pharmacies Chemotherapy Treatment, Transplantation, Others
The Pegfilgrastim Biosimilars Market Report 2022 is the most comprehensive report available on this market, and helps gain a truly global perspective as it covers 60 geographies worldwide. It identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches. The report provides market size and growth forecasts for the global template market, global market share, market segments, and so much more. Click Here To View Complete Report
Key Market Players Major companies in the market include Coherus BioSciences Intas Biopharmaceuticals Ltd Sandoz (Novartis) Mundipharma GmbH Biocon/Mylan Click Here To Get A Sample Report
How can the report help you? • Gain a truly global perspective with the most comprehensive market research report available on this market covering 60+ geographies • Create regional and country strategies on the basis of local data and analysis • Understand how the market is being affected by COVID-19 and how it is likely to emerge and grow as the impact of the coronavirus abates • Identify growth segments for investment • Outperform competitors using market forecast data and the market drivers and trends shaping the global market • Understand customers based on the latest market research findings • Benchmark performance against key competitors of the market Click Here To Get Purchase Options
Europe The Business Research Company 47 Anchorage Point, 42 Cuba Street, Canary Wharf, London, England, E14 8NE +44 207 1930 708 Americas The Business Research Company, 1295 N Providence Rd, Media, PA 19063, USA +1 3156230293 Get In Touch However you want to grow and expand, The Business Research Company can help as we provide research consulting solutions for businesses, government agencies consultancies, and market research companies. https://www.linkedin.com/company/thebusinessresearchcompany/ Asia The Business Research Company, 1st Floor, Anshu Colors Building, Road Number 1, Park View Enclave, Jubilee Hills, Hyderabad (India), 500033 +91 8897263534 https://twitter.com/tbrc_info https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ info@tbrc.info https://www.facebook.com/TheBusinessResearchCompany/